Clinical trial
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
NCT04528056 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
- Lead sponsor
- RenJi Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 1, 2020
- Completion date
- October 31, 2022
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.